Lumida
/RZLT
⌘K
Rezolute Inc

Rezolute Inc

RZLT
$4.22USD+1.20%+0.05 today

MARKET CAP

406.4M

P/E (TTM)

FWD P/E

DAY RANGE

$4 – $4

52W RANGE

$1
$11

AI Summary

Stalk
StalkMedium

RZLT remains in a Stage 2 advancing regime with a recent momentum breakout confirming demand. The medium-term bias is bullish and aligns with the established uptrend, but short-term conditions are unfavorable as price is extended above rising EMAs and in extreme overbought territory. Execution is deferred toward pullbacks into the breakout zone and rising EMAs for selective entry.

  • Breakeven by 2029 with projected $66.3M net profit.
  • 80% buy ratings and $9.38 average target imply 100% upside.
  • Earnings yield negative at –1.78% and profitability remains weak.
Full analysis →

Buying

5

institutions

Selling

6

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
RC

Ra Capital Management, L.P.

Q2 2026

BUY9.45 M49.11 M+265.04 K+75.4%0.43%
BI

Blackrock, Inc.

Q2 2026

BUY7.72 M40.14 M+1.40 M+108.4%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL4.66 M24.24 M+-386.38 K+57.4%0.03%
AC

Aqr Capital Management LLC

Q2 2026

BUY1.01 M5.24 M+211.27 K+115.7%0.00%
WP

Woodline Partners LP

Q2 2026

SELL611.80 K3.18 M+-611.80 K-14.8%0.01%
MM

Millennium Management LLC

Q2 2026

SELL517.23 K2.69 M+-1.00 M-41.9%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY322.59 K1.68 M+124.49 K+177.6%0.00%
AC

Adar1 Capital Management, LLC

Q2 2026

SELL48.68 K253.13 K+-10.00 K+41.4%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

BUY35.76 K182.35 K+4.30 K+103.4%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-157.71 K-100.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-14.13 K-100.0%0.00%